Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Nephrology
•
Transplant nephrology
How do you approach Chronic Active AMR concurrent with changes of CNI toxicity?
Related Questions
Do you require lupus patients with ESKD or advanced CKD to be on minimal immunosuppression around the time of kidney transplantation?
How would you manage persistent Norovirus diarrheal infections in a kidney transplant patient that are not responding to a decrease in the patient’s maintenance immunosuppressive regimen?
What are the best practices for preparing blood for transfusion in a patient with a kidney transplant to minimize complications?
What is your approach for patients with a history of nephrolithiasis who are being evaluated for living kidney donation?
What is your approach to management of tremors in a kidney transplant recipient who is taking a CNI for immunosuppression?
Are there instances when you use letermovir without the addition of acyclovir when managing a kidney transplant recipient for CMV prophylaxis?
What is the role of APOL1 genotyping in the evaluation of a living kidney donor?
Would you consider a BRCA carrier patient for kidney transplantation?
When do you recommend genetic testing prior to kidney transplantation for a patient with ESKD secondary to FSGS?
How do you approach treatment for patients with proliferative glomerulonephritis with monoclonal IgG deposits (PGNMID) with end-stage renal disease who are considering kidney transplant?
